Middle East and Africa Cold Sore Treatment Market – Industry Trends and Forecast to 2028

  • Pharmaceutical
  • Published Report
  • Mar 2021
  • MEA
  • 350 Pages
  • No of Tables: 117
  • No of Figures: 47

Middle East and Africa Cold Sore Treatment Market, By Strain Type (Herpes Simplex Type-1 Virus, Herpes Simplex Type-2 Virus), Therapeutics Type (Antiviral Agents, Analgesic Agents, Others), Drug Type (Branded and Generics), Dosage Type (Oral, Topical and Others), End User (Hospitals, Homecare, Specialty Clinics and Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy), Country (Saudi Arabia, South Africa, UAE, Israel, Kuwait, Egypt, Rest of Middle East and Africa) Industry Trends and Forecast to 2028

Middle East and Africa Cold Sore Treatment Market Market Analysis and Insights: Middle East and Africa Cold Sore Treatment Market

The cold sore treatment market is expected to gain market growth in the forecast period of 2021 to 2028. Data Bridge Market Research analyses that the market is growing with a CAGR of 5.1% in the forecast period of 2021 to 2028 and is expected to reach USD 34.54 million by 2028. The rising prevalence of herpes simplex virus (HSV) and proliferation in modes of transmission of HSV are the major drivers which has propelled the demand of the cold sore treatment market in the forecast period.

Cold sores or oral herpes are small blisters kind abrasions that occur due to the infection caused by the herpes simplex virus (HSV). Cold sores generally occur on the face, around the lips, chin, cheeks and nostrils. They generally cause pain and itching before they burst. HSV is one of the most common viruses found to affect the population and it is endemic throughout the world. Up to 90% of people around the world have at least one form of HSV.

The rising awareness programs regarding sexually transmitted diseases acts as driver for the cold sore treatment market. The lack of awareness about the disease would lead to rapid spread of the disease and hence prevention would be difficult. It would result in delay in drug distribution and this factor would hamper the cold sore treatment market growth. The rising disposable income acts as an opportunity for the growth of the cold sore treatment market. The rise in resistance towards acyclovir would result in exploitation of novel drugs being developed for antiviral therapy, this factor will pose as a challenge in the cold sore treatment market.

The cold sore treatment market report provides details of market share, new developments, and product pipeline analysis, impact of domestic and localised market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, product approvals, strategic decisions, product launches, geographic expansions, and technological innovations in the market. To understand the analysis and the cold sore treatment market scenario contact Data Bridge Market Research for an Analyst Brief, our team will help you create a revenue impact solution to achieve your desired goal.

Middle East and Africa Cold Sore Treatment Market Cold Sore Treatment Market Scope and Market Size

The cold sore treatment market is segmented into six notable segments which are based on the strain type, therapeutics type, drug type, dosage type, end user, distribution channel. The growth among segments helps you analyse niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.

  • On the basis of strain type, the cold sore treatment market is segmented into herpes simplex type-1 virus (HSV) and herpes simplex type-2 virus (HSV). In 2021, herpes simplex type-1 virus (HSV) segment is dominating due to its rapidly increasing prevalence worldwide.
  • On the basis by therapeutics, the cold sore treatment market is segmented into antiviral agents, analgesic agents and others. In 2021, antiviral agents segment is expected to dominate due to the increased count of infectious diseases caused by herpes simplex virus and enhanced product pipeline in antiviral agents.
  • On the basis of drug type, the cold sore treatment market is segmented into branded and generics. In 2021, generics segment is dominating because it’s less expensive as compared to branded drugs and due to the economical nature and increased usage for the treatment of cold sores.
  • On the basis of dosage type, the cold sore treatment market is segmented into oral, topical and others. In 2021, oral segment is expected to dominate because of its ease of absorption and flexibility to accommodate various types of drugs.
  • On the basis of end user, the cold sore treatment market is segmented into hospitals, homecare, specialty clinics and others. In 2021, homecare segment is dominating due to the ease in treatment at home and easy availability of drugs.
  • On the basis of distribution channel, the cold sore treatment market is segmented into hospital pharmacy, retail pharmacy and online pharmacy. In 2021, hospital pharmacy segment is expected to dominate due to the rise in access to cold sore medications and surge in number of prescriptions of cold sore medications on a daily basis.

Cold Sore Treatment Market Country Level Analysis

The cold sore treatment market is analysed and market size information is based on the country, strain type, therapeutics type, drug type, dosage type, end user, distribution channel as referenced above.

The countries covered in Middle East and Africa cold sore treatment market report are the Saudi Arabia, South Africa, UAE, Israel, Kuwait, Egypt, Rest of Middle East and Africa.

South Africa is expected to dominate the cold sore treatment market because of increasing demand for cold sore treatment due to rapidly rising patient population and advancements in technology.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, regulatory acts and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of Middle East and Africa brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.

Strategic Initiatives by Manufacturers is Creating New Opportunities for Players in the Cold Sore Treatment Market

The cold sore treatment market also provides you with detailed market analysis for every country growth in aesthetic industry with cold sore treatment sales, impact of advancement in the cold sore treatment and changes in regulatory scenarios with their support for the cold sore treatment market. The data is available for historic period 2010 to 2019.

Competitive Landscape and Cold Sore Treatment Market Share Analysis

The cold sore treatment market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, production sites and facilities, company strengths and weaknesses, product launch, product trials pipelines, product approvals, patents, product width and breadth, application dominance, technology lifeline curve. The above data points provided are only related to the company’s focus related to cold sore treatment market.

The major companies providing cold sore treatment are GlaxoSmithKline plc, Sun Pharmaceutical Industries Ltd., Glenmark Pharmaceutical Inc., U.S.A. (a subsidiary of Glenmark Pharmaceuticals Ltd.), AiCuris, Ortho dermatologics’ (a division of Bausch Health Companies Inc.), Aurobindo Pharma U.S.A. (a subsidiary of Aurobindo Pharma), WOCKHARDT, Novartis AG, Hikma Pharmaceuticals PLC, Hetero Healthcare Limited, Apotex Inc., Avanir Pharmaceuticals, Inc. among others. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.

Many product launches and agreements are also initiated by the companies’ worldwide which are also accelerating the cold sore treatment market.

For instance,

  • In December 2020, GlaxoSmithKline plc and Sanofi Inc. had declared the delay in the adjuvant recombinant protein based COVID-19 vaccine programme to enhance immune response in the elderly population. This initiative by both the companies would result in delay of the cold sore treatment products, less revenue and less growth in the market.

Collaboration, joint ventures and other strategies by the market players is enhancing the company market in the cold sore treatment market which also provides the benefit for organisation to improve their offering for cold sore treatment.

Customization Available: Middle East and Africa Cold Sore Treatment Market

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customised to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analysed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Factbook) or can assist you in creating presentations from the data sets available in the report.


SKU-

LIST OF TABLES

TABLE 1 MIDDLE EAST AND AFRICACOLD SORE TREATMENT MARKET, PIPELINE ANALYSIS

TABLE 2 GENERIC DRUGS USED FOR THE TREATMENT OF HSV (COLD SORES)

TABLE 3 MIDDLE EAST AND AFRICA COLD SORE TREATMENT MARKET, BY STRAIN TYPE 2019-2028 (USD MILLION)

TABLE 4 MIDDLE EAST AND AFRICA HERPES SIMPLEX TYPE 1 VIRUS IN COLD SORE TREATMENT MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 5 MIDDLE EAST AND AFRICA HERPES SIMPLEX TYPE 2 VIRUS IN COLD SORE TREATMENT MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 6 MIDDLE EAST AND AFRICA COLD SORE TREATMENT MARKET, BY THERAPEUTICS 2019-2028 (USD MILLION)

TABLE 7 MIDDLE EAST AND AFRICA ANTIVIRAL AGENTS IN COLD SORE TREATMENT MARKET, BY REGION 2019-2028 (USD MILLION)

TABLE 8 MIDDLE EAST AND AFRICA ANTIVIRAL AGENTS IN COLD SORE TREATMENT MARKET, BY THERAPEUTICS, 2019-2028 (USD MILLION)

TABLE 9 MIDDLE EAST AND AFRICA ANALGESIC AGENTS IN COLD SORE TREATMENT MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 10 MIDDLE EAST AND AFRICA ANALGESIC AGENTS IN COLD SORE TREATMENT MARKET, BY THERAPEUTICS, 2019-2028 (USD MILLION)

TABLE 11 MIDDLE EAST AND AFRICA OTHERS IN COLD SORE TREATMENT MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 12 MIDDLE EAST AND AFRICA COLD SORE TREATMENT MARKET, BY DRUG TYPE 2019-2028 (USD MILLION)

TABLE 13 MIDDLE EAST AND AFRICA GENERICS IN COLD SORE TREATMENT MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 14 MIDDLE EAST AND AFRICA GENERICS IN COLD SORE TREATMENT MARKET, BY DRUG TYPE, 2019-2028 (USD MILLION)

TABLE 15 MIDDLE EAST AND AFRICA BRANDED IN COLD SORE TREATMENT MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 16 MIDDLE EAST AND AFRICA BRANDED IN COLD SORE TREATMENT MARKET, BY DRUG TYPE, 2019-2028 (USD MILLION)

TABLE 17 MIDDLE EAST AND AFRICA COLD SORE TREATMENT MARKET, BY DOSAGE TYPE 2019-2028 (USD MILLION)

TABLE 18 MIDDLE EAST AND AFRICA ORAL IN COLD SORE TREATMENT MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 19 MIDDLE EAST AND AFRICA ORAL SEGMENT IN COLD SORE TREATMENT MARKET, BY DOSAGE TYPE, 2019-2028 (USD MILLION)

TABLE 20 MIDDLE EAST AND AFRICA TOPICAL SEGMENT IN COLD SORE TREATMENT MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 21 MIDDLE EAST AND AFRICA TOPICAL SEGMENT IN COLD SORE TREATMENT MARKET, BY DOSAGE TYPE, 2019-2028 (USD MILLION)

TABLE 22 MIDDLE EAST AND AFRICA OTHERS IN COLD SORE TREATMENT MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 23 MIDDLE EAST AND AFRICA COLD SORE TREATMENT MARKET, BY END USER 2019-2028 (USD MILLION)

TABLE 24 MIDDLE EAST AND AFRICA HOSPITALS IN COLD SORE TREATMENT MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 25 MIDDLE EAST AND AFRICA HOSPITALS IN COLD SORE TREATMENT MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 26 MIDDLE EAST AND AFRICA SPECIALTY CLINICS IN COLD SORE TREATMENT MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 27 MIDDLE EAST AND AFRICA OTHERS IN COLD SORE TREATMENT MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 28 MIDDLE EAST AND AFRICA COLD SORE TREATMENT MARKET, BY DISTRIBUTION CHANNEL 2019-2028 (USD MILLION)

TABLE 29 MIDDLE EAST AND AFRICA HOSPITALS PHARMACY IN COLD SORE TREATMENT MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 30 MIDDLE EAST AND AFRICA ONLINE PHARMACY IN COLD SORE TREATMENT MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 31 MIDDLE EAST AND AFRICA RETAIL PHARMACY IN COLD SORE TREATMENT MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 32 MIDDLE EAST & AFRICA COLD SORE TREATMENT MARKET, COUNTRY, 2021-2028 (USD MILLION)

TABLE 33 MIDDLE EAST & AFRICA COLD SORE TREATMENT MARKET, BY STRAIN TYPE, 2021-2028 (USD MILLION )

TABLE 34 MIDDLE EAST & AFRICA COLD SORE TREATMENT MARKET, BY THERAPEUTICS, 2021-2028 (USD MILLION)

TABLE 35 MIDDLE EAST & AFRICA ANTIVIRAL AGENTS IN COLD SORE TREATMENT MARKET, BY THERAPEUTICS, 2021-2028 (USD MILLION)

TABLE 36 MIDDLE EAST & AFRICA ANALGESIC AGENTS IN COLD SORE TREATMENT MARKET, BY THERAPEUTICS, 2021-2028 (USD MILLION)

TABLE 37 MIDDLE EAST & AFRICA COLD SORE TREATMENT MARKET, BY DRUG TYPE, 2021-2028 (USD MILLION)

TABLE 38 MIDDLE EAST & AFRICA GENERICS IN COLD SORE TREATMENT MARKET, BY DRUG TYPE, 2021-2028 (USD MILLION)

TABLE 39 MIDDLE EAST & AFRICA BRANDED IN COLD SORE TREATMENT MARKET, BY DRUG TYPE, 2021-2028 (USD MILLION)

TABLE 40 MIDDLE EAST & AFRICA COLD SORE TREATMENT MARKET, BY DOSAGE TYPE, 2021-2028 (USD MILLION)

TABLE 41 MIDDLE EAST & AFRICA ORAL IN COLD SORE TREATMENT MARKET, BY DOSAGE TYPE, 2021-2028 (USD MILLION)

TABLE 42 MIDDLE EAST & AFRICA TOPICAL IN COLD SORE TREATMENT MARKET, BY DOSAGE TYPE, 2021-2028 (USD MILLION)

TABLE 43 MIDDLE EAST & AFRICA COLD SORE TREATMENT MARKET, BY END USER, 2021-2028 (USD MILLION)

TABLE 44 MIDDLE EAST & AFRICA COLD SORE TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2021-2028 (USD MILLION)

TABLE 45 SOUTH AFRICA COLD SORE TREATMENT MARKET, BY STRAIN TYPE , 2021-2028 (USD MILLION )

TABLE 46 SOUTH AFRICA COLD SORE TREATMENT MARKET, BY THERAPEUTICS, 2021-2028 (USD MILLION )

TABLE 47 SOUTH AFRICA ANTI-VIRAL AGENTS IN COLD SORE TREATMENT MARKET, BY THERAPEUTICS, 2021-2028 (USD MILLION )

TABLE 48 SOUTH AFRICA ANALGESICS AGENTS IN COLD SORE TREATMENT MARKET, BY THERAPEUTICS , 2021-2028 (USD MILLION)

TABLE 49 SOUTH AFRICA COLD SORE TREATMENT MARKET, BY DRUG TYPE, 2021-2028 (USD MILLION)

TABLE 50 SOUTH AFRICA GENERICS IN COLD SORE TREATMENT MARKET, BY DRUG TYPE, 2021-2028 (USD MILLION)

TABLE 51 SOUTH AFRICA BRANDED IN COLD SORE TREATMENT MARKET, BY DRUG TYPE , 2021-2028 (USD MILLION)

TABLE 52 SOUTH AFRICA COLD SORE TREATMENT MARKET, BY DOSAGE TYPE , 2021-2028 (USD MILLION)

TABLE 53 SOUTH AFRICA ORAL IN COLD SORE TREATMENT MARKET, BY DOSAGE TYPE , 2021-2028 (USD MILLION)

TABLE 54 SOUTH AFRICA TOPICAL IN COLD SORE TREATMENT MARKET, BY DOSAGE TYPE, 2018-2027 (USD MILLION)

TABLE 55 SOUTH AFRICA COLD SORE TREATMENT MARKET, BY END USER, 2021-2028 (USD MILLION)

TABLE 56 SOUTH AFRICA COLD SORE TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2021-2028 (USD MILLION)

TABLE 57 EGYPT COLD SORE TREATMENT MARKET, BY TESTING TYPE, 2021-2028 (USD MILLION )

TABLE 58 EGYPT COLD SORE TREATMENT MARKET, BY THERAPEUTICS, 2021-2028 (USD MILLION )

TABLE 59 EGYPT ANTI-VIRAL AGENTS IN COLD SORE TREATMENT MARKET, BY THERAPEUTICS, 2021-2028 (USD MILLION )

TABLE 60 EGYPT ANALGESICS IN COLD SORE TREATMENT MARKET, BY THERAPEUTICS , 2021-2028 (USD MILLION)

TABLE 61 EGYPT COLD SORE TREATMENT MARKET, BY DRUG TYPE , 2021-2028 (USD MILLION)

TABLE 62 EGYPT GENERICS IN COLD SORE TREATMENT MARKET, BY DRUG TYPE TYPE, 2021-2028 (USD MILLION)

TABLE 63 EGYPT BRANDED IN COLD SORE TREATMENT MARKET, BY DRUG TYPE, 2021-2028 (USD MILLION)

TABLE 64 EGYPT COLD SORE TREATMENT MARKET, BY DOSAGE TYPE , 2021-2028 (USD MILLION)

TABLE 65 EGYPT ORAL IN COLD SORE TREATMENT MARKET, BY DOSAGE TYPE , 2021-2028 (USD MILLION)

TABLE 66 EGYPT TOPICAL IN COLD SORE TREATMENT MARKET, BY DOSAGE TYPE , 2021-2028 (USD MILLION)

TABLE 67 EGYPT COLD SORE TREATMENT MARKET, BY END USER, 2021-2028 (USD MILLION)

TABLE 68 EGYPT COLD SORE TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2021-2028 (USD MILLION)

TABLE 69 SAUDI ARABIA COLD SORE TREATMENT MARKET, BY STRAIN TYPE, 2021-2028 (USD MILLION )

TABLE 70 SAUDI ARABIA COLD SORE TREATMENT MARKET, BY THERAPEUTICS, 2021-2028 (USD MILLION )

TABLE 71 SAUDI ARABIA ANTI-VIRAL AGENTS IN COLD SORE TREATMENT MARKET, BY THERAPEUTICS, 2021-2028 (USD MILLION )

TABLE 72 SAUDI ARABIA ANALGESICS IN COLD SORE TREATMENT MARKET, BY THERAPEUTICS , 2021-2028 (USD MILLION)

TABLE 73 SAUDI ARABIA COLD SORE TREATMENT MARKET, BY DRUG TYPE , 2021-2028 (USD MILLION)

TABLE 74 SAUDI ARABIA GENERICS IN COLD SORE TREATMENT MARKET, BY DRUG TYPE, 2021-2028 (USD MILLION)

TABLE 75 SAUDI ARABIA BRANDED IN COLD SORE TREATMENT MARKET, BY DRUG TYPE, 2021-2028 (USD MILLION)

TABLE 76 SAUDI ARABIA COLD SORE TREATMENT MARKET, BY DOSAGE TYPE , 2021-2028 (USD MILLION)

TABLE 77 SAUDI ARABIA ORAL IN COLD SORE TREATMENT MARKET, BY DOSAGE TYPE , 2021-2028 (USD MILLION)

TABLE 78 SAUDI ARABIA TOPICAL IN COLD SORE TREATMENT MARKET, BY DOSAGE TYPE , 2021-2028 (USD MILLION)

TABLE 79 SAUDI ARABIA COLD SORE TREATMENT MARKET, BY END USER, 2021-2028 (USD MILLION)

TABLE 80 SAUDI ARABIA COLD SORE TREATMENT MARKET, BY DISTRIBUTION TYPE, 2021-2028 (USD MILLION)

TABLE 81 ISRAEL COLD SORE TREATMENT MARKET, BY STRAIN TYPE, 2021-2028 (USD MILLION )

TABLE 82 ISRAEL COLD SORE TREATMENT MARKET, BY THERAPEUTICS, 2021-2028 (USD MILLION )

TABLE 83 ISRAEL ANTI-VIRAL AGENTS IN COLD SORE TREATMENT MARKET, BY THERAPEUTICS, 2021-2028 (USD MILLION )

TABLE 84 ISRAEL ANALGESICS IN COLD SORE TREATMENT MARKET, BY THERAPEUTICS , 2021-2028 (USD MILLION)

TABLE 85 ISRAEL COLD SORE TREATMENT MARKET, BY DRUG TYPE , 2021-2028 (USD MILLION)

TABLE 86 ISRAEL GENERICS IN COLD SORE TREATMENT MARKET, BY DRUG TYPE, 2021-2028 (USD MILLION)

TABLE 87 ISRAEL BRANDED IN COLD SORE TREATMENT MARKET, BY DRUG TYPE, 2021-2028 (USD MILLION)

TABLE 88 ISRAEL COLD SORE TREATMENT MARKET, BY DOSAGE TYPE , 2021-2028 (USD MILLION)

TABLE 89 ISRAEL ORAL IN COLD SORE TREATMENT MARKET, BY DOSAGE TYPE , 2021-2028 (USD MILLION)

TABLE 90 ISRAEL TOPICAL IN COLD SORE TREATMENT MARKET, BY DOSAGE TYPE , 2021-2028 (USD MILLION)

TABLE 91 ISRAEL COLD SORE TREATMENT MARKET, BY END USER, 2021-2028 (USD MILLION)

TABLE 92 ISRAEL COLD SORE TREATMENT MARKET, BY DISTRIBUTION TYPE, 2021-2028 (USD MILLION)

TABLE 93 UAE COLD SORE TREATMENT MARKET, BY STRAIN TYPE, 2021-2028 (USD MILLION )

TABLE 94 UAE COLD SORE TREATMENT MARKET, BY THERAPEUTICS, 2021-2028 (USD MILLION )

TABLE 95 UAE ANTI-VIRAL AGENTS IN COLD SORE TREATMENT MARKET, BY THERAPEUTICS, 2021-2028 (USD MILLION )

TABLE 96 UAE ANALGESICS IN COLD SORE TREATMENT MARKET, BY THERAPEUTICS , 2021-2028 (USD MILLION)

TABLE 97 UAE COLD SORE TREATMENT MARKET, BY DRUG TYPE , 2021-2028 (USD MILLION)

TABLE 98 UAE GENERICS IN COLD SORE TREATMENT MARKET, BY DRUG TYPE, 2021-2028 (USD MILLION)

TABLE 99 UAE BRANDED IN COLD SORE TREATMENT MARKET, BY DRUG TYPE, 2021-2028 (USD MILLION)

TABLE 100 UAE COLD SORE TREATMENT MARKET, BY DOSAGE TYPE , 2021-2028 (USD MILLION)

TABLE 101 UAE ORAL IN COLD SORE TREATMENT MARKET, BY DOSAGE TYPE , 2021-2028 (USD MILLION)

TABLE 102 UAE TOPICAL IN COLD SORE TREATMENT MARKET, BY DOSAGE TYPE , 2021-2028 (USD MILLION)

TABLE 103 UAE COLD SORE TREATMENT MARKET, BY END USER, 2021-2028 (USD MILLION)

TABLE 104 UAE COLD SORE TREATMENT MARKET, BY DISTRIBUTION TYPE, 2021-2028 (USD MILLION)

TABLE 105 KUWAIT COLD SORE TREATMENT MARKET, BY STRAIN TYPE, 2021-2028 (USD MILLION )

TABLE 106 KUWAIT COLD SORE TREATMENT MARKET, BY THERAPEUTICS, 2021-2028 (USD MILLION )

TABLE 107 KUWAIT ANTI-VIRAL AGENTS IN COLD SORE TREATMENT MARKET, BY THERAPEUTICS, 2021-2028 (USD MILLION )

TABLE 108 KUWAIT ANALGESICS IN COLD SORE TREATMENT MARKET, BY THERAPEUTICS , 2021-2028 (USD MILLION)

TABLE 109 KUWAIT COLD SORE TREATMENT MARKET, BY DRUG TYPE , 2021-2028 (USD MILLION)

TABLE 110 KUWAIT GENERICS IN COLD SORE TREATMENT MARKET, BY DRUG TYPE, 2021-2028 (USD MILLION)

TABLE 111 KUWAIT BRANDED IN COLD SORE TREATMENT MARKET, BY DRUG TYPE, 2021-2028 (USD MILLION)

TABLE 112 KUWAIT COLD SORE TREATMENT MARKET, BY DOSAGE TYPE , 2021-2028 (USD MILLION)

TABLE 113 KUWAIT ORAL IN COLD SORE TREATMENT MARKET, BY DOSAGE TYPE , 2021-2028 (USD MILLION)

TABLE 114 KUWAIT TOPICAL IN COLD SORE TREATMENT MARKET, BY DOSAGE TYPE , 2021-2028 (USD MILLION)

TABLE 115 KUWAIT COLD SORE TREATMENT MARKET, BY END USER, 2021-2028 (USD MILLION)

TABLE 116 KUWAIT COLD SORE TREATMENT MARKET, BY DISTRIBUTION TYPE, 2021-2028 (USD MILLION)

TABLE 117 REST OF MIDDLE EAST & AFRICA COLD SORE TREATMENT MARKET, BY STRAIN TYPE, 2021-2028 (USD MILLION )

 

CHOOSE LICENCE TYPE
  • 4200.00
  • 3500.00
  • 2000.00
  • 5500.00
  • 7500.00
Why Choose Us
Unlocking New Opportunities on this Report Post Covid-19

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions